Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism
Arachchillage, D.R.J., Efthymiou, M., Mackie, I.J., Lawrie, A.S., Machin, S.J., Cohen, H.Volume:
135
Language:
english
Journal:
Thrombosis Research
DOI:
10.1016/j.thromres.2014.11.037
Date:
February, 2015
File:
PDF, 471 KB
english, 2015